United States Lipid Panel Testing Market Report, 2010 – 2020

1. India Adhesives Market Forecast & Opportunities, 2020 Opportunities, 2020 United States Lipid Panel Testing Market P h a r m a & H e a l t h c a r e C o n s u l t a n t s

2. Re s e a rc h M e t h o d o l o g y US Lipid Panel Testing Market Opportunities, 2020 Secondary Research Primary Research •Government websites •Company annual reports, white papers, investor presentations and financial reports •Identifying Key Opinion Leaders •Questionnaire Design •In-depth Interviews •Coverage across Value Chain market Preliminary Data Mining Qualitative and Quantitative research Data Validation, Analysis and Interpretation Data validation through Primary & Secondary outreach, data analysis and interpretation of key findings Market Estimation & Forecasting Bottom-Up or Top-down approach for Market size estimation. Historical trend examination. Impact analysis of drivers and challenges to market growth. Statistical evaluation to develop the actual forecast. CAGR (2015E-2020F): X% 2 © Pharmaion 2015E 2016F 2017F 2018F 2019F 2020F

3. Ta b l e o f C o n te n t s S. No. Contents 1. Lipid Panel Testing Overview 2. Research Methodology 3. Analyst View 4. Global Lipid Panel Testing Market Overview 5. United States Lipid Panel Testing Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Type 5.2.3. By End User 5.2.2. By Region 6. United Sates Lipid Panel Testing Service Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Type 6.2.2. By Service Provider 6.2.3 By Company 7. United Sates Lipid Panel Testing Device Market Outlook 7.1. Market Size & Forecast 3 7.1.1. By Value © Pharmaion

4. Ta b l e o f C o n te n t s S. No. Contents 7.2. Market Share & Forecast 7.2.1. By Type 7.2.2 By End User 8. Market Dynamics 8.1.1 Drivers 8.1.2. Challenges 9. Market Trends & Developments 9.1. Online Blood Labs 9.2. Non invasive Cholesterol Testing 9.3 Inexpensive Lipid Panel Test 9.4 Mobile based SmartCARD Technology 9.5 Home Based Testing device 10. Policy & Regulatory Landscape 11. United States Economic Profile 12. Competitive Landscape 12.1. Competition Benchmarking (Market Attractiveness) 12.2. Company Profiles 12.2.1. Quest Diagnostics, Inc. 12.2.2 Alere Inc. 12.3.3 Polymer Technology Systems, Inc. 12.4.4 Roche Diagnostics Corporation 3 12.5.5 Siemens Healthcare Diagnostics, Inc. © Pharmaion

5. Ta b l e o f C o n te n t s S. No. Contents 12.2.6. Laboratory Corporation of America 12.2.7. Ortho-Clinical Diagnostics, Inc. 12.2.8. Abbott Laboratories 12.2.9. Danaher Corporation 12.2.10. Atherotech, Inc. 13. Strategic Recommendations 14. About Us & Disclaimer 4 © Pharmaion

6. I n d u s t r y B r i e f United States Lipid Panel Testing Market to Cross US$ 6 billion by 2019 Growing consumer awareness coupled with increasing prevalence of cholesterol related diseases to drive United States lipid panel testing market through 2020 According to recently published Pharmaion report,“United States Lipid Panel Testing Market Opportunities, 2010 - 2020”, the lipid panel test market in the United States is anticipated to cross the US$ 6 billion mark by 2019. A wide array of factors anticipated to influence the growth of lipid panel testing market in the US during forecast period include high incidence rate of cardiovascular diseases, growing aging population, rising prevalence of chronic diseases and favorable reimbursement policies. Moreover, increasing automation in laboratories leading to higher sensitivity and faster test results is forecast to further fuel the market of lipid panel testing in the United States during 2015 - 2020. On the basis of services offered, the market has been segmented into two broad categories, namely, Lipid Panel Testing Services and Lipid Panel Testing Devices. Among these categories, lipid panel testing services segment dominated the United States lipid panel testing market in 2014. The segment is anticipated to continue its dominance during forecast period as well on account of the implementation of Affordable Care Act, in 2010. Under this act, cholesterol screenings and treatments were made mandatory for all the citizens of the United States. The largest market share in the United States lipid panel testing market was captured by the country’s South region, followed by the West, Midwest and Northeast regions. “Growing number of initiatives by the government and non-government organizations is resulting in increasing awareness about cardiovascular diseases. In 2011, Centres for Disease Control and Prevention (CDC) launched an initiative named as “The Million Hearts” with an aim to prevent 1 million heart attacks and strokes by 2017. In 2015, an awareness steering committee was set up by The National Forum for Heart Disease & Stroke Prevention, a non-profit organization, which is involved in spreading awareness regarding cholesterol related diseases across the US. All these factors are expected to have a positive impact on the country’s lipid panel testing market through 2020.” said Mr. Karan Chechi, Research Director, with Pharmaion Consultants, a research based global pharmaceutical and healthcare consulting firm. 6 © Pharmaion

7. L i p i d Pa n e l Te s t i n g O ve r v i e w Lipids are defined as a group of fats or fat-like substance which are an important constituents of cells and sources of energy. The monitoring and maintenance of appropriate levels of these lipids is essential to live a healthy life. Lipid Panel Testing (LPT) is the diagnostic method used for analysis of cholesterol level in the person’s blood. It is majorly recommended by the doctor as a part of risk assessment to determine the possibility of heart diseases in an individual. The results of these tests plays an important role in deciding the treatment depending upon the cholesterol levels are at high risk or are at borderline. Table 1: United States Government Recommended Cut-off Levels for Cholesterol Testing Acceptable (mg/dL) Borderline (mg/dL) Test High (mg/dL) XXXX XXXX XXXX XXXX Children and Adolescents XXXX XXXX XXXX XXXX XXXX XXXX XXXX XXXX Young Adults XXXX XXXX XXXX XXXX 7 © Pharmaion

8. S a m p l e D a t a - S n a p s h o t United States Lipid Panel Testing Market Size, By United States Lipid Panel Testing Market Size, By Region, By Value, 2010-2020 (USD Billion) Region, By Value, 2010-2014 (USD Billion) 18.00%18.10%18.20%18.30%18.40%18.50%18.60%18.70%18.80%18.90%19.00% Northeas t 20.00%20.10%20.20%20.30%20.40%20.50%20.60%20.70%20.80%20.90%21.00% Midwest 20.00%20.10%20.20%20.30%20.40%20.50%20.60%20.70%20.80%20.90%21.00% West 30.00%30.10%30.20%30.30%30.40%30.50%30.60%30.70%30.80%30.90%31.00% South West Region OWNERSHIP STRUCTURE, 2015 Midwest Region 5.00 4.00 5.00 Public Share Holding, 34.00% 3.00 4.00 2.00 3.00 1.00 Shareholder Promoting & Promoting Groups, 33.00% 2.00 1.00 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 Non-Institutions, 33.00% Northeast Region South Region 5.00 5.00 4.00 4.00 3.00 3.00 2.00 2.00 1.00 1.00 OWNERSHIP STRUCTURE (2015) 2010 2011 2012 2013 2014 2010 2011 2012 2013 2014 Institution al Ownershi… Others, 50.00% United States Lipid Panel Test Market Share, By End User/Provider, By Value, 2010-2020F 58.00% 58.10% 58.20% 58.30% 58.40% 58.50% 58.60% 58.70% 58.80% 58.90% 59.00% Hospital s United States Lipid Panel Testing Market Indepen dent Labs POLs & Others 28.00% 28.10% 28.20% 28.30% 28.40% 28.50% 28.60% 28.70% 28.80% 28.90% 29.00% Size, By Value, 2010-2020F (USD Billion) 12 11 10 9 8.00% 8.10% 8.20% 8.30% 8.40% 8.50% 8.60% 8.70% 8.80% 8.90% 9.00% 8 7 9 5 4 3 2 1 2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F © Pharmaion 2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

9. Re p o r t O rd e r i n g Report Name: United States Lipid Panel Testing Market Opportunities, 2010 – 2020 Report Price License Type Price Single User License $2500 Single User License Print $3000 Enterprise License $5000 To View Sample OR Purchase Report 9 © Pharmaion

10. A b o u t U s & D i s c l a i m e r About Us Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry. Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound by legacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients. Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them with comprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consulting requirements. Related Reports India Stem Cell Market Opportunities, 2010-2020 Global Tissue Engineered Medical Devices Market Opportunities, 2010-2020 Global Cervical Cancer Vaccine Market Opportunities, 2010-2020 Disclaimer The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained from various sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants. NORTH AMERICA Pharmaion Consultants LLC 708 3RD Avenue, 6th Floor, New York, NY, United State, 10017 sales@pharmaion.com +1 646 360 1656 www.pharmaion.com ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A – 51, Sector 57, Noida, National Capital Region, India - 201301 sales@pharmaion.com +91 - 120 - 452 3900 www.pharmaion.com 10 © Pharmaion